Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. (3002)
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. (statistical code 3002): exports in August 2026 were JPY 44,701,086,000 (+1.5% year on year), quantity 59,891 KG, unit price JPY 744,981 per KG. Main destinations: Switzerland (66.1%), United States of America (7.5%), Austria (5.2%), Germany (3.9%), Taiwan (3.9%). Figures for August 2026 are revised.
Imports in the same month were JPY 231,494,028,000, a trade deficit of JPY 186,792,942,000. (imports: preliminary; exports: revised)
Import statistics for this code
Monthly statistics
| Month | Status | Export value | Quantity | Unit price | Year-on-year |
|---|---|---|---|---|---|
| August 2026 | revised | JPY 44,701,086,000 | 59,891 | JPY 744,981 | +1.5% |
| July 2026 | revised | JPY 36,436,152,000 | 64,439 | JPY 563,740 | +49.1% |
| June 2026 | revised | JPY 20,994,637,000 | 62,526 | JPY 335,377 | -45.5% |
| May 2026 | revised | JPY 22,515,505,000 | 74,179 | JPY 302,703 | -10.3% |
| April 2026 | revised | JPY 35,587,734,000 | 58,985 | JPY 601,949 | -0.9% |
| March 2026 | revised | JPY 19,972,992,000 | 65,755 | JPY 302,796 | -9.1% |
| February 2026 | revised | JPY 35,862,925,000 | 65,099 | JPY 549,532 | -4.9% |
| January 2026 | revised | JPY 38,145,594,000 | 76,588 | JPY 496,874 | +15.7% |
| December 2025 | revised (second) | JPY 25,570,591,000 | 61,714 | JPY 413,624 | -27.1% |
| November 2025 | revised (second) | JPY 27,712,005,000 | 68,584 | JPY 402,812 | +33.0% |
| October 2025 | revised (second) | JPY 44,420,158,000 | 68,615 | JPY 643,607 | +66.4% |
| September 2025 | revised (second) | JPY 28,014,605,000 | 57,611 | JPY 483,888 | -10.8% |
| August 2025 | revised (second) | JPY 44,031,786,000 | 56,950 | JPY 772,633 | +47.8% |
| July 2025 | revised (second) | JPY 24,431,052,000 | 67,449 | JPY 361,615 | -48.4% |
| June 2025 | revised (second) | JPY 38,537,138,000 | 93,643 | JPY 410,632 | +24.1% |
| May 2025 | revised (second) | JPY 25,102,402,000 | 56,812 | JPY 440,187 | -37.7% |
| April 2025 | revised (second) | JPY 35,912,029,000 | 84,896 | JPY 422,478 | -7.4% |
| March 2025 | revised (second) | JPY 21,964,233,000 | 60,411 | JPY 362,635 | +6.7% |
| February 2025 | revised (second) | JPY 37,721,594,000 | 72,259 | JPY 520,388 | +31.0% |
| January 2025 | revised (second) | JPY 32,959,582,000 | 71,645 | JPY 457,879 | +33.2% |
| December 2024 | final | JPY 35,053,541,000 | 55,581 | JPY 630,239 | +41.0% |
| November 2024 | final | JPY 20,842,039,000 | 55,574 | JPY 373,666 | -55.3% |
| October 2024 | final | JPY 26,694,315,000 | 65,185 | JPY 408,911 | +40.4% |
| September 2024 | final | JPY 31,417,836,000 | 60,740 | JPY 516,931 | +4.4% |
Subcategories
- Antisera and other blood fractions
- Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale
- Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale
- Immunological products, put up in measured doses or in forms or packings for retail sale
- Vaccines for human medicine
- Vaccines for veterinary medicine
- Other
- Cell therapy products
- Other
- Other
API and MCP
No API key required. An optional API key gives you a dedicated quota of 1,000 requests per day that is not affected by congestion (free at https://data.washutrading.com/register/).
Example API request for this item: https://data.washutrading.com/api/v1/series?code=3002&flow=export